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ABSTRACT

A RADICAL CONJUGATE ADDITION APPROACH TO THE TOTAL SYNTHESIS
OF CELOGENTIN C

Steven Gene Capps
Department of Chemistry and Biochemistry
Master of Science

The synthesis of five chiral DBFOX (dibenzofuran-oxazoline) ligands with either
aryl or benzyl substituents will be presented. The requisite amino alcohols were obtained
with high enantioselectivity either commercially (DBFOX/Bn), via Sharpless asymmetric
aminohydroxylation (DBFOX/Nap, DBFOX/t-BuPh, DBFOX/Pip), or via phase-transfer
catalyzed asymmetric alkylation (DBFOX/MeNap).
iv

These ligands, complexed with

Mg(NTf2)2, were used as Lewis acid promoters of enantioselective radical conjugate
additions to α/β-unsaturated nitro-amides/esters. A summary of these results is presented
and discussed.
These findings led us to believe that our initial binding model between metal,
ligand, and substrate was flawed. Thus, we figured that if we started with a functionality
known to bind to both nitro groups and carbonyls, and then introduced a chiral element
for control, we may be able to improve the β-carbon enantioselectivity. We have tried to
accomplish this via hydrogen-bonding ligands (ureas and thioureas). Initial studies on
achiral versions of this concept are discussed.
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CHAPTER 1. INTRODUCTION
1.1 Celogentin C
Celogentin C (1, Figure 1), isolated by Kobayashi and co-workers from the seeds
of Celosia argentea, is known to inhibit polymerization of microtubule protein (IC50 =
0.8 μM), and is the most potent natural product within the Moroidin family (Figure 2).1
This renders Celogentin C a promising anti-mitotic and anti-tumor agent. Structurally,
Celogentin C is a bicyclic octapeptide with two fused rings, possessing two unusual
linkages, the first being the C-N bond between tryptophan and histidine residues to form
the right-hand ring.
The second interesting feature of 1 is the C-C leucine-tryptophan linkage in the
left-hand ring. This linkage forms a functionality known as a β-substituted amino acid.
Since a conventional peptide coupling reaction would be unsuitable for this bond
formation, a strategy for forming the core left-hand ring structure with an alkene, then
installing the isopropyl group via a radical conjugate addition with high
enantioselectivity, has been designed. To date, no total synthesis of this natural product
has been published, though a model synthesis of the right-hand ring was published by the
Castle group in 2006.2

Two other researchers in the field, Moody3 and Hutton,4 have

also worked toward and published results in the pursuit of this attractive synthetic target.
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Figure 1. Celogentin C (1)

Figure 2. Moroidin and Other Celogentins
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1.2 Radical Conjugate Addition
The field of radical chemistry has blossomed within the past ten years, leading to
a great deal of research. Traditionally, radicals have been thought of as mostly neutral,
non-polar species. However, this paradigm has shifted, and recent work in radical donors
and acceptors has been widespread, leading to a type of radical reaction known as a
radical conjugate addition (RCA). The RCA is the use of a nucleophilic radical, often
alkyl, which adds to an electron-deficient radical acceptor, such as an α, β-unsaturated
carbonyl compound.

In 2001, Zhang published a review on intramolecular RCA

reactions,5 and Castle published another review in 2005.6 The scope and utility of RCA
reactions is wide, with macrocyclizations,7 alkyl additions,8 and radical cascade9
mechanisms, with reagents such as SmI210 or R3SnH.11 Sibi was particularly noteworthy
as a pioneer in Lewis-acid- promotion of intermolecular RCA reactions, especially using
chiral auxiliaries and chiral Lewis acid complexes to promote stereoselectivity via
oxazolidinones12 and bis-oxazolines13 (Scheme 1).

His research also led to milder

conditions for many products of other major reactions, such as aldol-type products.14

Scheme 1. Sibi’s Early Work with Enantioselective RCA Reactions
3

In 2005, the Castle group published work that detailed how the DBFOX/Ph
ligand, developed by Kanemasa and Curran (2, Figure 4)15 was effective at facilitating
the enantioselective synthesis of β-substituted α-amino acids via a Lewis acid-promoted
RCA (Scheme 1).16 This substructure is a commonly-occurring motif in many natural
products, including 1.17

Such structures are also attractive synthetic targets as

constrained analogues of natural α-amino acids.18

While other methods exist for

constructing these analogues,19 the radical conjugate addition is attractive due to the mild
conditions that do not interfere with acidic protons, such as peptide amide hydrogens.20
Thus, one could generate a library of β-substituted α-amino acids from complex peptidic
structures containing a radical acceptor, such as an electron-deficient alkene, by varying
the nature of the radical.
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N

Ph

Ph

O

Figure 3. DBFOX/Ph (2)

R1 = NHBn or OMe, R2 = H, OMe, or F
50−88% ee, syn/anti = 1.4-2.6:1
Scheme 2. Mg/DBFOX-promoted Enantioselective Radical Conjugate Additions
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1.3 Initial Results
After using a Knoevenagel condensation to prepare the requisite α-nitro, α,βunsaturated esters, a wide range of Lewis acids were tested in the RCA. Mg and Zn gave
the most promising initial results, but the most important factor of this stage was the
observation of a slow addition in the absence of any Lewis acid promoter, as long as a
large excess of alkyl iodide was used (20 eq).

This crucial observation allowed a

calculation of relative rates of acceleration for various conditions.
In order to determine if a stereoselective RCA would be possible, the Castle group
experimented with Bu3SnD.

The α-hydrogen in the product which is installed via

hydrogen atom abstraction is quite acidic, due to conjugation with the carbonyl and the
presence of the nitro group. Thus, the RCA would be ill-suited to applications in organic
synthesis, if epimerization of the newly-formed stereocenter could not be prevented. By
substituting Bu3SnD for Bu3SnH, previous group members were able to observe D-H
exchange in the products when H2O was used in the workup of amide substrates, or when
SiO2 chromatography was employed in purification. Hydrogenation of the NO2 group in
the crude products, followed by N-Cbz protection, allowed purification of amide and
ester products with α-D labels, indicating that the stereocenter was not epimerizing. This
finding set the possibility for using chiral Lewis acid complexes to control the H atom
abstraction, and potentially the addition, in a stereoselective RCA.
Work on determining the best chiral Lewis acid complex was next. Previous
group members tried using variations of Curran’s DBFOX/Ph ligand with various R
groups α to the phenyl group (Figure 4). Dimethyl- or dibutyl-DBFOX ligands proved to

5

be less effective than the parent ligand (2), presumably because the added bulk interfered
in the complexation with both Lewis acid and substrate.

Figure 4. DBFOX/Ph-like Ligands (R = H, Me, n-Bu)
In order to accurately assess the selectivity of their methodology, the Castle group
had to determine the absolute stereochemistry of their addition products. This was
accomplished by reduction of the nitro group to an amine, then hydrolysis of the benzyl
amide to an acid, to form known amino acids (Scheme 3).

Syn

Anti

Scheme 3. Absolute Configuration Determination
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Comparison of resulting products’ NMR and optical rotation data allowed them to
quantify the amount of syn product and anti product (named as shown in Scheme 3)
obtained from the RCA. From this data, they were able to determine the selectivity at the
α-carbon and the β-carbon of the nitroalkene, which they dubbed “α ee” and “β ee.” The
results of their research were that they could obtain a high α ee (up to 83%), but the β ee
was low (up to 25%).

1.4 Empirical Substrate-Lewis Acid Binding Model
The main disadvantage to the DBFOX/Ph-promoted radical conjugate additions is
the lack of stereoselectivity at the β-carbon. This leads to a poor diastereomeric ratio,
even though the enantiomeric excess of each diastereomer is good. Based on these
findings, the Castle group suggested a binding model of the metal/ligand/substrate that
explained the differences in selectivity between the two carbon stereocenters (Figure 5).
The octahedral magnesium complex possessed a literature precedent,21 and also helped to
explain why the hydrogen abstraction by the α-carbonyl radical is more selective than the
alkyl radical addition to the β-carbon. This model postulates that the aryl group (phenyl
in this case) is used to shield one face of the alkene. Thus, by increasing the size of the
aryl group, we could increase the effective shielding at the β-carbon, thereby increasing
the diastereomeric ratios.

7

Figure 5. Substrate-Lewis Acid Binding Model
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CHAPTER 2. LIGAND PREPARATION
2.1 Amino Alcohol Preparation
The simplest way in which to increase the bulk of the aryl group attached to the
DBFOX backbone structure was to vary the amino alcohol used and then follow the
synthesis of 2 by Curran and Kanemasa.1 With five modified DBFOX ligands in mind,
we set out to synthesize the five amino alcohol precursors (Figure 1). For the first three
ligands (3-5), we envisioned a simple two-step synthesis to install the functional groups
and stereocenter.
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Figure 1. Proposed DBFOX Ligands
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DBFOX/p-tBuPh (4)
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Naphthyl Cbz amino alcohol (Cbz Nap, 11) was synthesized in two steps from 2vinyl naphthalene (8) via Sharpless asymmetric aminohydroxylation (SAA)1 as
previously reported in moderate yields and excellent enantioselectivity (Scheme 1).2 The
p-tBuPh Cbz amino alcohol (Cbz tBu, 12) was synthesized in the same manner, with
slightly lower yields, but excellent selectivity (>99% ee). The benzodioxole Cbz amino
alcohol (Cbz Pip, 13) was obtained in the same way with moderate yield, but again,
excellent selectivity (95% ee).

Scheme 1. SAA Reaction

One source of the low yields in the SAA reaction is the formation of the
regioisomeric amino alcohol.

By keeping the reaction at 0 ºC, this byproduct is

minimized, affording a 3:1 ratio or better favoring the desired product. The exact amount
of regioisomer formed in each case was not quantified, but was roughly calculable from
crude 1H NMR by the differences in methylene hydrogen chemical shifts.
With the SAA products in hand, the Cbz protecting group was removed via
hydrogenolysis with 10% Pd/C, 1 atm of H2, and NH4OAc to increase the palladium
turnover, presumably by dissociating the Pd/amine complex. Due to the nature of the

11

hydrogenation as a heterogeneous mixture, the rate was variable, but the reaction was
usually done within 24 hours. A 20% loading of Pd/C did not seem to accelerate the
reaction, but adding more than three equivalents of NH4OAc resulted in sluggish
reactivity. Using a higher pressure of H2 proved to be counterproductive and removed
the benzylic amine entirely. The crude product, with conversion verified by TLC and
NMR, was taken directly on to the next stage of synthesis.
The fourth amino alcohol was commercially available at >99% ee as Dphenylalaninol (14, Figure 2).

The fifth amino alcohol was neither commercially

available nor did it have an available vinyl precursor. Methylenenaphthyl amino alcohol
(16)3 was synthesized in three steps from 2-(bromomethyl)naphthalene (15) via a chiral
phase-transfer-catalyzed alkylation (Scheme 2).4 The resulting iminoester (95% ee) was
first hydrolyzed in dilute acid, then reduced with LiBH4 to give the S-amino alcohol,
whereas all the others were R-amino alcohols. This choice of stereochemistry was made
based on availability of cinchonidine-derived phase-transfer catalyst. Initial reductions
were carried out using LAH in refluxing THF overnight, but yields were typically low
(50−70%). Fortunately, Dr. Biplab Banerjee, a co-worker in the Castle lab, was able to
develop the borohydride conditions shown in Scheme 2 to improve the yield of this step.

Figure 2. D-phenylalaninol (14)
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Scheme 2. Synthesis of MeNap Amino Alcohol

2.2 Bisoxazoline Formation
With all five amino alcohols in hand, we proceeded to follow the synthesis laid
out by Curran and Kanemasa for 2.5 From commercially available dibenzofuran, a
directed ortho-metallation, followed by installing a carboxylate at those two positions,
gave the diacid. Conversion to the diacid chloride proceeded smoothly to provide the
precursor (17) for the DBFOX ligand formation.
The amidation of 17 with amino alcohols 18 and 21 proceeded smoothly within a
day at room temperature, analogous to the procedure outlined for DBFOX/Ph.
Amidations with amino alcohols 19, 20, and 22 were sluggish and often low-yielding.
This was remedied by elevating the temperature up to 90 ºC and allowing for longer
reaction times. Presumably, the added bulk of the amino alcohols led to the decreased
reactivity relative to phenylglycinol, though this does not help to explain the relative rates
of Nap and MeNap.

Furthermore, there were multiple cases of mono-amidated

intermediate being isolated (as R-COCl or R-CO2H), indicating that the second amidation
was much more sluggish than the first.
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Table 1. DBFOX/R Amidations

R

Solvent

Temp (ºC)

Time (hrs)

Prd

Yield (%)

Nap (18)

CHCl3

35

24

23

91

tBu (19)

DMF

90

68

24

72

Pip (20)

DMF

90

67

25

88

Bn (21)

THF

45

107

26

79

MeNap (22)

DMF

120

86

27

67

We speculated that one possibility as to the relative reactivity of the tBu and Pip
amino alcohols compared to phenylglycinol could be attributed to the residual
ammonium acetate used in the hydrogenolysis of the Cbz protecting group prior to the
amidation. NH4OAc is only mildly soluble in CDCl3, and NMR’s obtained of crude
amino alcohols show roaming ammonium peaks, which is no surprise. However, what is
surprising are occasional shifts of 0.1−0.2 ppm of the acetate peak were observed in some
samples. This suggests that an acetate salt could have been slowing the nucleophilic
attack of the nitrogen lone pair to the benzodioxole acid chloride.
experimentation would be needed to verify or disprove this hypothesis.
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Further

The final step from the Curran-Kanemasa synthesis of 2 is a cyclodehydration
mediated by diethylaminosulfur trifluoride (DAST).5 Applied to the new amides, DAST
cyclodehydrations were unreliable and often low-yielding.

The original procedure

reported that the purity of the diamide precursor was essential to the success of the DAST
procedure. Due to the scale of many of the ligand preparations, recrystallization was
impractical and often failed.

The majority of the amides were purified by column

chromatography (SiO2), which likely left trace impurities responsible for the capricious
yields.
A second procedure was reported by Evans and Woerpel in which they
cyclodehydrated similar alkyl amino amides via tosyl chloride, Et3N, and dimethylamino
pyridine (DMAP).6 This procedure allowed activation of the sulfoxide with DMAP,
driving the tosylate formation to induce the nucleophilic attack of the amide oxygen in
cyclization. While this procedure proved to be more reliable and robust than the DASTmediated procedure, reactions were more sluggish (2-3 days) and lower-yielding.
Increasing the amount of DMAP to stoichiometric amounts remedied this issue, but
quickly became impractical, due to the difficulty of monitoring the reaction by TLC and
NMR from DMAP overlapping product signals.
Fortunately for us, an article was discovered around the same time that dealt with
highly-activated DMAP analogues, particularly 4-pyrrolidinopyridine (PPY).6

A

catalytic amount (10 or 20 mol %) of PPY mediated the cyclodehydration of amides 2327 within 24 hours with good yields (Table 2).
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Table 2. DBFOX/R Cyclodehydrations

O
O

NH

O

PPY (10 mol %)
Et3N, TsCl

HN
R

R
HO

CH2Cl2
19–23 h

O
O

O
N

N

R

OH

R

R

Time (hrs)

Prd

Yield (%)

Nap (23)

19

3

88

tBu (24)

19

4

58

Pip (25)

20

5

64

Bn (26)

19

6

83

MeNap (27)

23

7

82
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CHAPTER 3. RADICAL CONJUGATE ADDITIONS WITH NEW DBFOX LIGANDS
3.1 Ligand Evaluation on Model Substrate
With five new DBFOX ligands in hand, the next step of the project was to test
each of these ligands in place of DBFOX/Ph (2) on the model substrate. All other
conditions were kept constant. Since achieving high selectivity in both the addition and
H-atom abstraction steps were key, the full three-step sequence to inhibit epimerization at
the α-carbon was performed (Scheme 1). Only one change was made to the procedure as
constituted in the 2005 paper:1 the ligand and Lewis acid were stirred overnight in order
to ensure complexation.

Early trials resulted in a large percentage of products

characterized by the reduction of the double bond, rather than the radical addition. We
theorized that one possible cause of this increase in byproducts was a lack of association
between the new ligands, which are bulkier than 2, and Mg(NTf2)2. Thus, without the
electron-rich DBFOX ligands to lower the Lewis acidity of the Mg, conjugate reduction
by Bu3SnH was favored, a hypothesis supported by observations from the initial work,1
where stronger Lewis acids promoted the conjugate reduction at a slow rate.
Upon increasing the initial complexation time, the percentage of reduction
product was minimized and yields of addition product were increased. The kinetic extent
of complexation was first monitored by NMR, but it soon became apparent that an easier
visual cue could be used: Initial solubility of Mg(NTf2)2 in CH2Cl2 was minor, resulting
in a cloudy suspension. Upon complexation with the ligand, it dissolved and the solution
cleared.
It was our initial hypothesis that these bulkier DBFOX ligands would increase the
diastereoselectivity of the addition step over the results reported with 2. Initial trials with
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DBFOX/Nap (3) and DBFOX/p-tBuPh (4) confirmed this hypothesis (Table 1).
DBFOX/Bn (6) and DBFOX/MeNap (7) also showed increased selectivity at the βcarbon stereocenter. Surprisingly, DBFOX/Pip (5) showed worse selectivity than 2,
leading to a possible theory that the heteroatoms in the dioxole ring participated in some
way to our detriment. Also surprising was the significantly lower yields obtained when 7
was used. Since the improvements over 2 were minimal (and less than those observed
with 3), this was never optimized. Perhaps the lower yields are due to an even slower
rate of ligand-Mg complexation, and could potentially be remedied by a longer initial
stirring before substrate addition.

Table 1. Ligand Evaluation in Radical Conjugate Addition

Ligand

% Yield

syn/anti

% ee (syn, anti)a

α ee, β ee (%)

2b

76

1.4:1

88, 76

83, 20

3

65

1.8:1

96, 97

96, 30

4

57

1.6:1

84, 79

28, 28

5

75

1.2:1

76, 79

78, 12

6

80

1.5:1

82, 80

81, 25

7

44

1.6:1

92, 90c

91, 25

a

Determined by chiral HPLC (see Ch. 5 for details). b Data from Ref. 1.
enantiomers were opposite those obtained from reactions with 3−6.
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c

Major

3.2 Substrate Scope of DBFOX/Nap-Mediated Additions
With the improvements observed at both stereocenters using 3, we set out to
investigate if these trends held with the other amide and ester radical acceptors used in
the initial studies with 2 (Table 2). Amide substrates 35 and 37 underwent the Mg/3promoted radical conjugate addition with improved enantio- and diastereoselectivity.
The best results were still from 33, which contained the more electron-rich pmethoxyphenyl alkene β-substituent.

However, when esters 39, 41, and 43 were

employed, lower yields and lower selectivities were observed for all three substrates.
One possible explanation for this flip-flop in the trend could be the carbonylLewis acid complex interaction. Amides have a stronger tendacy to bind to Lewis acids2
because of the resonance between the nitrogen lone pair and carbonyl oxygen, which
results in a greater negative charge on the more electronegative oxygen (Figure 1). Esters
do not share this level of resonance, since the oxygen is less prone to lone pair donation.
This difference alone does not serve as an adequate explanation for the significant
changes observed in the radical conjugate additions between the amide and ester
substrates, as well as the trend differences in data resulting from the switch from
DBFOX/Ph to DBFOX/Nap.
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Table 2. Reaction Scope of DBFOX/Nap (3)

a

20

% Yield syn/anti

% ee (syn, anti)a

Substrate

Ligand

33

2b

76

1.4:1

88, 76

33

3

65

1.8:1

96, 97

35

2b

66

1.4:1

64, 62

35

3

60

1.7:1

73, 71

37

2b

59

1.6:1

72, 50

37

3

63

2.0:1

80, 61

39

2b

75

2.6:1

21, 28

39

3

38

2.2:1

11, 15

41

2b

60

1.7:1

9, 17

41

3

28

1.3:1

2, 5

43

2b

66

1.7:1

6, 12

45

3

17

1.4:1

3, 3

Determined by chiral HPLC (See Ch. 5 for details).

b

Data from Ref. 1

Right Structure Contributes More
to Actual Structure of Amide

Left Structure Contributes More
to Actual Structure of Ester

Figure 1. Difference Between Amide and Ester Carbonyls

3.3 Methodology Considerations
Faced with these findings, we began to wonder if our empirical binding model
might be inaccurate, because the carbonyl difference had such a major effect on the
reaction, which suggests a primarily monodentate substrate-auxiliary interaction instead
of the postulated bidentate interaction. Although nitro-Lewis acid complexation has been
reported previously,3 the data, which show a minimal improvement in the
stereoselectivity at the β-carbon of the amide substrates, combined with a sharp decline of
selectivity with the ester substrates, argue against this model.
The reactions summarized in Tables 1 and 2 were all conducted with a substantial
quantity of Bu3SnH (three additions, 2.5 equivalents each) to ensure complete
conversion. The goal of this project was to enhance the scope, value, and practicality of
this

methodology,

so

we

explored

the

same

reaction

of

the

DBFOX/Nap−Mg(NTf2)2−directed addition of isopropyl radical to 33 with one-half the
amount of tin per loading (Scheme 2). While yields were slightly lower, the dr and ee
values remained comparable. No other values were changed. Further optimization and
experimentation could restore the reaction to its previous levels of yield or higher in the
future. These findings are fortuitous, as the only troublesome reagent in the radical
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conjugate addition sequence is the tin.

However, its impact can be minimized by

employing a procedure published by Harrowven,4 in which a 10% w/w mixture of ground
KF in silica gel was used in the purification to remove a significant level of tin byproduct
impurity from the Cbz-protected amino amides and esters.

Scheme 1. Radical Conjugate Addition with Reduced Tin Loadings

3.4 References
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1995, 60, 3576.
3. Liu, H.; Xu, J.; Du, D.-M. Org. Lett. 2007, 9, 4725.
4. Harroven, D. C.; Guy, I. L. Chem. Commun. 2004, 1968.
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CHAPTER 4. INITIAL EXAMINATION OF HYDROGEN-BONDING CATALYSTS
4.1 Ureas and Thioureas
Evidence was obtained through experimentation that suggested our hypothesized
binding model was inaccurate. Thus, we began to explore the possibility of other systems
that are known to interact with both nitro groups and carbonyls, such as hydrogen bond
donors Hydrogen bonding reagents have been extensively used in chemistry, and have
received special attention in recent literature as part of a complex chemical scaffold to
bring two reacting elements together.1

We wanted to use these same principles to

hydrogen bond to both Lewis basic groups, inducing a conformational change that would
twist the carbonyl out of the plane from the rest of the nitroalkene (Figure 1). Removal
of this conjugation may cause the amino portion of the amide to preferentially shield one
face of the alkene from radical attack. One reason this might occur is that the dipole
alignment in the natural planar conformer between the nitro group and carbonyl group
destabilizes the compound. By hydrogen bonding to a rigid backbone, a twist can be
imposed to bring these two dipoles out of plane with each other, relieving that electronic
interference. Of course, it is difficult to predict which functional group will twist.

H

H
O

H
O

N

1. H-bond donors f ix
substrate orientation
2.
H-bonding
causes
O
amide carbonyl to twist
out of conjugation with
NHBn
nitroalkene
3. Twisting of amide leads
to shielding of one face
R
of alkene

H

Figure 1. Proposed Catalyst-Substrate Binding
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Rigid hydrogen bond donors would be the best option for the proposed binding
shown in Figure 1. A fixed backbone combined with a chiral element away from the
binding site would be able to transfer that chirality via sterics to the proposed “twisted”
binding model. We decided to survey a series of ureas and thioureas, as these functional
groups have exhibited hydrogen bonding to nitro groups.2-4

Takenaka recently

discovered an aminopyridinium ion that also complexes well with nitroalkenes.5 A set of
seven donors were proposed as simple, achiral ligands to test the extent to which
hydrogen bonding will catalyze the radical conjugate addition (Figure 2). We hoped that
the thioureas would act as the better catalyst, since thioureas are more Lewis acidic than
ureas. However, we are aware that the thiocarbonyl may interfere with the radical
chemistry.

Figure 2. Hydrogen Bond Donors

4.2 Radical Conjugate Additions with Achiral Hydrogen Bond Donors
Compounds 41−47 were synthesized and we performed the radical conjugate
addition as outlined previously, substituting the DBFOX/Mg complex with the various
24

hydrogen bond donors. Since 41−47 are achiral, we performed only the radical conjugate
addition, unlike the previous studies where precautions were taken to prevent
epimerization by reducing the nitroalkene product to an amine, then protecting with
CbzCl before purifying.
Initial results on the screening process were difficult to unravel, as tin removal
became a major problem. Nonetheless, we were able to see the peaks corresponding to
the substrate starting material and the addition product on both MS and 1H NMR. Using
ligand 45, we saw an approximate two to one ratio of product to starting material, with no
evidence of reduction byproducts. Masses for these fractions are unreliable still, due to
the tin contamination and multiple purification attempts.

4.3 Conclusions
The syntheses of five new DBFOX ligands were accomplished, and these ligands
were then tested in a radical conjugate addition reaction. DBFOX/Nap exhibited minor
increases in enantio- and diastereoselectivity over DBFOX/Ph with α/β-unsaturated-αnitroamide substrates, but the corresponding nitroesters exhibited decreased yields and
selectivities. This data caused us to revisit our empirical binding model, which had
postulated an octahedral magnesium complex with a bidentate complexation to the
substrate. With the major differences between substrate reactivity, we had to consider
that the carbonyl−Lewis acid coordination was major compared to the nitro−Lewis acid
complexation, which may or may not exist. We then began model studies utilizing
hydrogen-bond donors, which are known to bind to both nitro groups and carbonyls. The
results of these studies are still in progress.
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CHAPTER 5. EXPERIMENTAL AND SPECTROSCOPIC DATA
5.1 General Methods
Tetrahydrofuran, N,N-dimethylformamide, triethylamine, methylene chloride, and
methanol were dried by passage through a Glass Contour solvent drying system
containing cylinders of activated alumina.1 Flash chromatography was carried out using
60–230 mesh silica gel. 1H NMR spectra were obtained on a Varian 500 MHz
spectrometer, with chloroform (7.27 ppm) or tetramethylsilane (0.00 ppm) as an internal
reference. Signals are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet),
dd (doublet of doublets), dt (doublet of triplets), br s (broad singlet), m (multiplet).
Coupling constants are reported in hertz (Hz). 13C NMR spectra were obtained on a
Varian spectrometer operating at 125 MHz, with chloroform (77.23 ppm) as internal
reference. Infrared spectra were obtained on a Nicolet Avatar 360 FT-IR Spectrometer.
Optical rotations were obtained using a Perkin-Elmer 241 Polarimeter. Mass spectral
data were obtained using ESI techniques from the Brigham Young University mass
spectrometry facility.

5.2 Experimental Details
(R)-Benzyl 2-hydroxy-1-(naphthalene-2-yl)ethylcarbamate (11). To a stirred
solution of benzyl carbamate (1.47 g, 9.74 mmol) in 1-propanol (13 mL) was added
freshly prepared sodium hydroxide solution (414 mg in 13 mL H2O), with a 3 mL aliquot
set aside. Freshly prepared sodium hypochlorite (1.20 g, 11.0 mmol) was then added,
followed by (DHQD)2PHAL (40 mg, 0.05 mmol). The mixture was stirred until
homogeneous, then immersed in a 0 °C ice bath. After 10 minutes, 2-vinylnaphthalene
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(502.3 mg, 3.26 mmol, 8) was added. The aliquot of NaOH solution was used to dissolve
the K2OsO2(OH)4 (25.4 mg, 0.07 mmol). This was then added to the bulk solution. The
solution was stirred at 0°C for 4.5 hours, at which time the stirring ceased and the flask
was cooled to -25°C to precipitate product. The product was collected by filtration,
washed with cold 1:1 nPrOH-H2O, and dried overnight on the benchtop to afford product
(288.3 mg, 0.90 mmol, 68%) as a white solid. If product did not precipitate, the solution
was quenched with satd. aq. sodium sulfite, then stirred at 0°C for 15 mins. The aqueous
layer was separated and extracted with 3 x 15 mL of EtOAc. The combined organic
layers were washed with water (10 mL), brine (10 mL), dried over anhydrous magnesium
sulfate, and concentrated in vacuo. Flash chromatography (SiO2, 2 x 20 cm, 30-50%
EtOAc/hexane gradient elution) provided product, occasionally contaminated with
regioisomer. Spectral data for 11 were identical to those previously reported.2
(R)-Benzyl 1-(4-tert-butylphenyl)-2-hydroxyethylcarbamate (12).

Prepared

from p-tert-butylstyrene (9, 150 μL, 135 mg, 0.83 mmol) according to the procedure
given for the preparation of 11.

Compound 12 (109.5 mg, 0.33 mmol, 40%) was

obtained as a white solid: [α]25D –3.6 (c 0.50, EtOH); 1H NMR (CDCl3, 500 MHz) δ
7.40–7.27 (m, 9H), 5.20–5.12 (m, 1H), 5.13 (s 2H), 4.86–4.80 (m, 1H), 3.62–3.54 (m,
1H), 3.37–3.31 (m, 1H), 2.52 (s, 1H), 1.32 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ 157.3,
151.3, 138.7, 136.6, 128.8 (2C), 128.44 (2C), 128.40, 125.9 (2C), 125.8 (2C), 73.7, 67.2,
48.6, 34.8, 31.6 (3C); IR (film) νmax 3377, 3260, 3062, 2924, 2855, 1696, 1282, 1157,
1084, 989 cm–1; HRMS (ESI) m/z 328.19092 (MH+, C20H25NO2H requires 328.19072).
12 was obtained in >99% ee, as analyzed by HPLC (Chiralcel OD-H, 65:35 hexane:iPrOH, 0.70 mL/min; tR = 7.9 min, 9.4 min (major)).

28

(R)-Benzyl

1-(benzo[d][1,3]dioxol-5-yl)-2-hydroxyethylcarbamate

(13).

Prepared from 5-vinylbenzo[d][1,3]dioxole3 (10, 96 mg, 0.65 mmol) according to the
procedure given for the preparation of 11. Compound 13 (102 mg, 0.32 mmol, 50%) was
obtained as an off-white solid: [α]25D –10.9 (c 1.0, EtOH); 1H NMR (CDCl3, 500 MHz)
δ 7.40–7.27 (m, 5H), 6.80–6.76 (m, 3H), 5.95 (s 2H), 5.44 (d, J = 3.5 Hz, 1H), 5.13 (d, J
= 12.0 Hz, 1H), 5.08 (d, J = 12.0 Hz, 1H), 4.80–4.71 (m, 1H), 3.91–3.75 (s, 2H), 2.10 (s,
1H); 13C NMR (CDCl3, 125 MHz) δ 156.5, 148.3, 147.5, 136.4, 133.2, 128.8 (2C), 128.5
(3C), 120.1, 108.8, 107.3, 101.4, 67.3, 66.8, 57.1; IR (film) νmax 3395, 3310, 3090, 3050,
2950, 2895, 2780, 1697, 1504, 1440, 1370, 1320, 1244, 1038, 940 cm–1; HRMS (ESI)
m/z 338.09908 (MNa+, C17H17NO5Na requires 338.09989). 13 was obtained in 95% ee,
as analyzed by HPLC (Chiralcel OD-H, 80:20 hexane:i-PrOH, 0.80 mL/min; tR = 10.0
min (major), 15.5 min).
Hydrogenolysis of the Cbz group: To a solution of 11 (16.2 mg, 0.050 mmol) in
MeOH (2 mL) was added solid ammonium acetate (12 mg, 0.15 mmol). After stirring for
a minute, 10% Pd/C (2.3 mg, 20% w/w to substrate) was added. The vial was evacuated,
then a positive pressure of H2 was applied. This was repeated twice more to ensure the
absence of air in the reaction container. The positive pressure of H2 was kept on the
system for 23 hours, at which time the flask was evacuated and opened and the solution
was run through a plug of Celite to remove the Pd/C. The solution was washed with 5
mL water to remove NH4OAc. Reaction completion was verified by NMR and TLC.
(S)-tert-Butyl

2-(diphenylmethyleneamino)-3-(naphthalene-2-yl)propanoate

(15): A solution of N-(diphenylmethylene)glycine tert-butyl ester (50.0 mg, 0.17 mmol)
and N-(2’,3’,4’-trifluoro)benzylhydrocinchonidinium bromide4 (9.5 mg, 0.017 mmol) in
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PhCH3–CHCl3 (7:3, 750 μL) was treated with 2-(bromomethyl)naphthalene (96.6 mg,
0.423 mmol). The solution was then cooled to –20 °C, treated with 50% aqueous KOH
(250 μL), and stirred at –20 °C for 12 h. The resultant mixture was diluted with Et2O (20
mL), washed with H2O (3 × 5 mL), dried (Na2SO4), and concentrated in vacuo. Flash
chromatography (SiO2, 1.5 × 25 cm, 10% EtOAc–hexanes elution) afforded 15 (62.0 mg,
0.14 mmol, 84%) as a yellow oil. Spectral data for this compound were identical to those
previously reported.5 15 was obtained in 95% ee, as analyzed by HPLC (Chiralcel ODH, 99.8:0.2 hexane:i-PrOH, 1.0 mL/min; tR = 9.5 min (major), 15.6 min).
(S)-2-Amino-3-(naphthalene-2-yl)propan-1-ol (16). A solution of 15 (150 mg,
0.34 mmol) in THF (2.0 mL) was treated with HCl (2 N, 500 μL) and stirred at rt for 4 h.
The resultant mixture was treated with sat aq NaHCO3 (1.5 mL) and extracted with
EtOAc (3 × 3 mL). The combined organic layers were dried (Na2SO4) and concentrated
in vacuo. Flash chromatography (SiO2, 1.0 × 18 cm, 100% EtOAc elution) afforded the
free amine (77.0 mg, 0.28 mmol, 83%).
A solution of this amine (40 mg, 0.15 mmol) in anhydrous Et2O (2.0 mL) was
treated with anhydrous CH3OH (8.8 μL, 7.0 mg, 0.22 mmol) followed by LiBH4 (4.8 mg,
0.22 mmol). The resultant mixture was stirred at rt under Ar for 16 h, then treated with
H2O (0.5 mL) and CH3OH (0.3 mL) and extracted with EtOAc (3 × 10 mL). The
combined organic layers were washed with brine (10 mL), dried (Na2SO4), and
concentrated in vacuo to afford 16 (26.9 mg, 0.13 mmol, 91%) as an off-white solid.
Spectral data for this compound were identical to those previously reported.6
N4,N6-bis((R)-2-Hydroxy-1-(napthalen-2-yl)ethyl)dibenzo[b,d]furan-4,6dicarboxamide (18): A flask with magnetic stirbar was charged with diacid chloride 17
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(74.7 mg, 0.25 mmol) and anhydrous solvent (CHCl3, pre-treated with basic alumina, 2
mL). This was placed into a 0°C ice bath under argon and stirred for 5 minutes. A
solution of deprotected naphthyl amino alcohol (90 mg, 0.48 mmol), Et3N (0.08 mL, 0.51
mmol), and CHCl3 (1 mL) was added dropwise to the dibenzofuran. The flask was then
heated in an oil bath to 35 °C for 24 hours. Solid ammonium chloride (50 mg) was added
to quench the reaction, and this was stirred at room temperature for 30 mins. Then, the
solution was filtered. The solid was stirred in THF for an additional 30 mins, and then
filtered again.

The combined organic extracts were concentrated in vacuo.

Flash

chromatography (SiO2, 1.5 x 20 cm, 50%/80%/100% EtOAc-hexanes gradient elution)
afforded 18 (133.9 mg, 0.23 mmol, 91%) as a yellow oil: [α]25D +131 (c 0.1, 95%
EtOH); 1H NMR (CDCl3, 500 MHz) δ 8.14 (d, J = 7.5 Hz, 2H), 8.04 (d, J = 7.5 Hz, 2H),
8.01 (d, J = 6.5 Hz, 2H), 7.87 (s, 2H), 7.80−7.72 (m, 8H), 7.53−7.47 (m, 4H), 7.44−7.39
(m, 2H), 5.45 (dd, J = 10.0, 6.5 Hz, 2H), 4.10−4.04 (m, 2H), 4.02−3.97 (m, 2H), 3.34 (br
s, 2H);
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C NMR (CDCl3, 125 MHz) δ 164.5 (2C), 153.4 (2C), 136.5 (2C), 133.3 (2C),

132.9 (2C), 128.6 (2C), 127.9 (2C), 127.6 (2C), 127.5 (2C), 126.2 (2C), 125.9 (2C),
125.6 (2C), 124.8 (2C), 124.3 (2C), 124.2 (2C), 123.6 (2C), 118.9 (2C), 66.0 (2C), 56.6
(2C); IR (film) νmax 3325, 2920, 2349, 1731, 1695, 1682, 1658, 1641, 1592, 1547, 1539,
1531, 1462, 1060, 954, 806, 737, 617, 559 cm-1; HRMS (ESI) m/z 595.22258 (MH+,
C38H30N2O5H requires 595.22275).
N4,N6-bis((R)-1-(4-tert-Butylphenyl)-2-hydroxyethyl)dibenzo[b,d]furan-4,6dicarboxamide (19). Compound 19 was prepared from deprotected p-tert-butyl phenyl
amino alcohol (200 mg, 1.03 mmol) and 17 (160 mg, 0.54 mmol) according to the
procedure given for the preparation of 18, with the exceptions that DMF (6 mL total) was
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used as the reaction solvent and the reaction was stirred at 90 °C for 68 h. Compound 19
(240 mg, 0.39 mmol, 72%) was obtained as a light yellow solid: [α]25D +0.8 (c 0.25,
EtOH); 1H NMR (CDCl3, 500 MHz, mixture of rotamers) δ 8.30 and 8.21 (2d, J = 7.5
and 7.5 Hz, 2H), 8.09 and 8.02 (2d, J = 8.0 and 8.0 Hz, 2H), 7.98–7.94 and 7.86–7.82
(2m, 2H), 7.52 and 7.48 (2t, J = 7.5 and 7.5 Hz, 2H), 7.40–7.36 (m, 8H), 5.09 (d, J = 9.5
Hz, 2H), 4.31–4.21 (m, 2H), 4.07 and 4.01 and 3.71 (3 br s, 2H), 3.51 (t, J = 11.5 Hz,
2H), 1.34 (s, 18H); 13C NMR (CDCl3, 125 MHz, mixture of rotamers) δ 164.2 and 164.0
(2C), 152.6 and 152.4 (2C), 151.0 (2C), 138.7 and 138.6 (2C), 129.6 and 129.3 (2C),
125.7 (4C), 125.5 (4C), 124.2 and 124.1 (2C), 124.0 (2C), 123.9 and 123.8 (2C), 118.5
(2C), 73.1 and 72.9 (2C), 47.6 and 47.5 (2C), 34.6 (2C), 31.3 (6C); IR (film) νmax 3418,
2961, 2868, 1644, 1543, 1426, 1407, 1298, 1270, 1181, 1157, 1108, 1084, 910 cm–1;
HRMS (ESI) m/z 607.31665 (MH+, C38H42N2O5H requires 607.31341).
N4,N6-bis((R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-hydroxyethyl)dibenzo[b,d]furan4,6-dicarboxamide (20). Compound 20 was prepared from deprotected piperonal amino
alcohol (9.0 mg, 0.050 mmol) and 17 (7.9 mg, 0.027 mmol) according to the procedure
given for the synthesis of 18, with the exceptions that DMF (3 mL total) was used as the
reaction solvent and the reaction was stirred at 90 °C for 67 h. Compound 20 (13.9 mg,
0.024 mmol, 88%) was obtained as white solid: [α]25D +7.6 (c 0.25, EtOH); 1H NMR
(CDCl3, 500 MHz) δ 8.11 (d, J = 7.5 Hz, 2H), 7.99 (d, J = 7.5 Hz, 2H), 7.85 (d, J = 6.5
Hz, 2H), 7.49–7.45 (m, 2H), 6.93–6.90 (m, 4H), 6.79 (dd, J = 7.5, 2.0 Hz, 2H), 5.92 (s,
4H), 5.21 (d, J = 3.5 Hz, 2H), 4.04–3.98 (m, 2H), 3.96–3.89 (m, 2H), 3.33 (s, 2H); 13C
NMR (CDCl3, 125 MHz) δ 164.4 (2C), 153.4 (2C) 148.0 (2C), 147.1 (2C), 133.1 (2C),
127.4 (2C), 124.4 (2C), 124.3 (2C), 123.7 (2C), 120.1 (2C), 118.8 (2C), 108.5 (2C),
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107.3 (2C), 101.1 (2C), 66.2 (2C), 56.2 (2C); IR (film) νmax 3274, 2920, 2868, 1638,
1542, 1503, 1488, 1440, 1233, 1191, 1040, 932 cm–1; HRMS (ESI) m/z 583.17130 (MH+,
C32H26N2O9H requires 583.17111).
N4,N6-bis((R)-1-Hydroxy-3-phenylpropan-2-yl)dibenzo[b,d]furan-4,6dicarboxamide (21). Compound 21 was prepared from 14 (19.1 mg, 0.12 mmol) and 17
(18.5 mg, 0.063 mmol) according to the procedure given for the synthesis of 18, with the
exceptions that THF (2 mL total) was used as the reaction solvent and the reaction was
stirred at 45 °C for 107 h. Compound 21 (26.1 mg, 0.050 mmol, 79%) was obtained as a
white solid: [α]25D +75 (c 0.50, EtOH); 1H NMR (CDCl3, 500 MHz) δ 8.05 (d, J = 7.5
Hz, 2H), 7.92 (d, J = 8.0 Hz, 2H), 7.52 (d, J = 7.5 Hz, 2H), 7.44 (t, J = 8.0 Hz, 2H), 7.38–
7.29 (m, 8H), 7.24 (t, J = 7.5 Hz, 2H), 4.49–4.39 (m, 2H), 3.90 (d, J = 10.0 Hz, 2H), 3.79
(d, J = 12.0 Hz, 2H), 3.45 (s, 2H), 3.16 (dd, J = 13.5, 6.0 Hz, 2H), 3.05 (dd, J = 13.5, 8.0
Hz, 2H); 13C NMR (CDCl3, 125 MHz) δ 164.6 (2C), 153.4 (2C), 138.2 (2C), 129.7 (4C),
128.9 (4C), 127.7 (2C), 126.9 (2C), 124.6 (2C), 124.4 (2C), 123.9 (2C), 119.2 (2C), 63.3
(2C), 53.8 (2C), 37.2 (2C); IR (film) νmax 3390, 2924, 2853, 1657, 1629, 1617, 1538,
1457, 1261, 1194, 1086, 1035 cm–1; HRMS (ESI) m/z 523.22020 (MH+, C32H30N2O5H
requires 523.22275).
N4,N6-bis((S)-1-Hydroxy-3-(naphthalen-2-yl)propan-2-yl)dibenzo[b,d]furan4,6-dicarboxamide (22). Compound 22 was prepared from 16 (34.0 mg, 0.17 mmol)
and 17 (23.4 mg, 0.080 mmol) according to the procedure given for the synthesis of 18,
with the exceptions that DMF (5 mL total) was used as the reaction solvent and the
reaction was stirred at 120 °C for 86 h. Compound 22 (33.2 mg, 0.053 mmol, 67%) was
obtained as a yellow oil: [α]25D –19 (c 0.17, EtOH); 1H NMR (CDCl3, 500 MHz) δ 8.10
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(d, J = 7.5 Hz, 2H), 7.96 (d, J = 7.5 Hz, 2H), 7.84–7.78 (m, 6H), 7.78–7.74 (m, 2H), 7.61
(d, J = 7.5 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 7.48–7.42 (m, 6H), 4.57–4.49 (m, 2H), 3.94
(dd, J = 11.5, 3.0 Hz, 2H), 3.84 (dd, J = 11.5, 4.0 Hz, 2H), 3.35 (dd, J = 13.5, 6.0 Hz,
2H), 3.23 (dd, J = 13.0, 8.5 Hz, 2H), 2.97 (br s, 2H);

13

C NMR (CDCl3, 125 MHz) δ

164.3 (2C), 153.3 (2C), 135.6 (2C), 133.7 (2C), 132.3 (2C), 128.3 (2C), 128.0 (2C),
127.8 (2C), 127.7 (2C), 127.6 (2C), 127.5 (2C), 126.1 (2C), 125.5 (2C), 124.4 (2C),
124.2 (2C), 123.7 (2C), 119.0 (2C), 62.9 (2C), 53.6 (2C), 37.1 (2C); IR (film) νmax 3392,
2923, 2869, 1651, 1536, 1399, 1375, 1325, 1245, 1200, 1195, 1080, 1025, 1015, 1003,
925 cm–1; HRMS (ESI) m/z 623.25377 (MH+, C40H34N2O5H requires 623.25405).
4,6-bis((R)-4-(Naphthalen-2-yl)-4,5-dihydrooxazol-2-yl)dibenzo[b,d]furan
(23). A solution of 18 (59.2 mg, 0.10 mmol) in anhydrous CH2Cl2 (1.5 mL) was treated
with Et3N (40 μL, 29.1 mg, 0.29 mmol) and 4-pyrrolidinopyridine (4.8 mg, 0.032 mmol).
The mixture was stirred at 0 °C for 10 min, then treated dropwise with a solution of TsCl
(45.9 mg, 0.23 mmol) in anhydrous CH2Cl2 (1.5 mL).

The resultant mixture was

vigorously stirred at rt for 19 h, then treated with sat aq NH4Cl (7 mL) and extracted with
CH2Cl2 (3 x 10 mL).

The combined organic layers were dried (Na2SO4) and

concentrated in vacuo. Flash chromatography (SiO2, 1.5 x 19 cm, 20−100% EtOAc in
hexanes gradient elution) afforded 23 (49.1 mg, 0.088 mmol, 88%) as an off-white solid:
[α]25D -28 (c 0.13, 95% EtOH); 1H NMR (CDCl3, 500 MHz) δ 8.24 (d, J = 8.0 Hz, 2H),
8.17 (d, J = 7.5 Hz, 2H), 7.87 (s, 2H), 7.80 (d, J = 8.0 Hz, 4H), 7.77 (d, J = 8.5 Hz, 2H),
7.53−7.48 (m, 4H), 7.44−7.36 (m, 4H), 5.68 (t, J = 9.0 Hz, 2H), 4.96 (t, J = 9.0 Hz, 2H),
4.40 (t, J = 8.0 Hz, 2H);

13

C NMR (CDCl3, 125 MHz) δ 162.5 (2C), 154.4 (2C), 145.3

(2C), 139.8 (2C), 133.4 (2C), 132.8 (2C), 128.8 (2C), 128.6 (2C), 127.9 (2C), 127.7 (2C),
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126.2 (2C), 125.8 (2C), 125.5 (2C), 124.9 (2C), 124.8 (2C), 123.9 (2C), 123.1 (2C), 74.8
(2C), 70.1 (2C); IR (film) νmax 2928, 1650, 1494, 1427, 1185, 1124, 984, 747, 700 cm-1;
HRMS (ESI) m/z 559.20263 (MH+, C38H26N2O3H requires 559.20162).
4,6-bis((R)-4-(4-tert-Butylphenyl)-4,5-dihydrooxazol-2-yl)dibenzo[b,d]furan
(24). Compound 24 was prepared from 19 (2.9 mg, 0.0048 mmol) according to the
procedure given for the synthesis of 23. Compound 24 (1.6 mg, 0.0028 mmol, 58%) was
obtained as an off-white solid: [α]25D +36 (c 0.05, 95% EtOH); 1H NMR (CDCl3, 500
MHz) δ 8.15 (t, J = 7.5 Hz, 4H), 7.50–7.32 (m, 10H), 5.70 (dt, J = 18.0, 9.0 Hz, 2H),
4.66–4.58 (m, 2H), 4.25–4.15 (m, 2H), 1.32 (s, 18H);

13

C NMR (CDCl3, 125 MHz) δ

161.0 (2C), 154.4 (2C), 151.2 (2C), 137.9 (2C), 128.5 (2C), 125.9 (4C), 125.6 (4C),
124.8 (2C), 123.6 (2C), 123.0 (2C), 113.5 (2C), 80.6 (2C), 63.4 (2C), 34.6 (2C), 31.3
(6C); IR (film) νmax 2959, 1651, 1427, 1185, 1120, 1059 cm–1; HRMS (ESI) m/z
571.29856 (MH+, C38H38N2O3H requires 571.29552).
4,6-bis((R)-4-(Benzo[d][1,3]dioxol-5-yl)-4,5-dihydrooxazol-2-yl)dibenzo[b,d]
furan (25). Compound 25 was prepared from 20 (19.1 mg, 0.0328 mmol) according to
the procedure given for the synthesis of 23. Compound 25 (11.9 mg, 0.0210 mmol, 64%)
was obtained as a beige solid: [α]25D −2.5 (c 0.12, EtOH); 1H NMR (CDCl3, 500 MHz) δ
8.16 (d, J = 7.5 Hz, 2H), 8.13 (d, J = 8.0 Hz, 2H), 7.45 (t, J = 8.0 Hz, 2H), 6.98 (s, 2H),
6.87 (d, J = 7.5 Hz, 2H), 6.78 (d, J = 8.5 Hz, 2H), 5.92 (d, J = 6.0 Hz, 4H), 5.46 (t, J =
9.5 Hz, 2H), 4.91 (t, J = 9.0 Hz, 2H), 4.35 (t, J = 8.5 Hz, 2H);

13

C NMR (CDCl3, 125

MHz) δ 162.2 (2C), 154.3 (2C), 147.9 (2C), 146.9 (2C), 136.5 (2C), 128.7 (2C), 124.8
(2C), 123.8 (2C), 123.0 (2C), 120.0 (2C), 113.2 (2C), 108.3 (2C), 107.4 (2C), 101.0 (2C),
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74.8 (2C), 69.6 (2C); IR (film) νmax 2924, 1654, 1489, 1428, 1248, 1188, 1039, 935, 749
cm–1; HRMS (ESI) m/z 547.14990, (MH+, C32H22N2O7H requires 547.14998).
4,6-bis((R)-4-Benzyl-4,5-dihydrooxazol-2-yl)dibenzo[b,d]

furan

(26).

Compound 26 was prepared from 21 (66.4 mg, 0.13 mmol) according to the procedure
given for the synthesis of 23, with the exception that 0.20 equiv of 4-pyrrolidinopyridine
were employed. Compound 26 (50.0 mg, 0.11 mmol, 83%) was obtained as a beige
solid: [α]25D –43 (c 0.26, EtOH); 1H NMR (CDCl3, 500 MHz) δ 8.12 (t, J = 7.5 Hz, 4H),
7.44 (t, J = 7.5 Hz, 2H), 7.35–7.29 (m, 8H), 7.26−7.21 (m, 2H), 4.78−4.70 (m, 2H), 4.52
(t, J = 8.5 Hz, 2H), 4.25 (t, J = 8.0 Hz, 2H), 3.39 (dd, J = 14.0, 4.5 Hz, 2H), 2.87 (dd, J =
13.5, 4.5 Hz, 2H);

13

C NMR (CDCl3, 125 MHz) δ 161.7 (2C), 154.2 (2C), 138.1 (2C),

129.3 (4C), 128.7 (4C), 128.6 (2C), 126.5 (2C), 124.8 (2C), 123.7 (2C), 123.0 (2C),
113.3 (2C), 72.0 (2C), 67.9 (2C), 41.7 (2C); IR (film) νmax 2923, 1651, 1494, 1427, 1185,
1125, 984 cm–1; HRMS (ESI) m/z 487.20193 (MH+, C32H26N2O3H requires 487.20162).
4,6-bis((S)-4-(Naphthalen-2-ylmethyl)-4,5-dihydrooxazol-2-yl)dibenzo[b,d]
furan (27). Compound 27 was prepared from 22 (36.8 mg, 0.059 mmol) according to the
procedure given for the synthesis of 23, with the exception that 0.20 equiv of 4pyrrolidinopyridine were employed. Compound 27 (28.3 mg, 0.048 mmol, 82%) was
obtained as a beige solid: [α]25D +72 (c 0.17, 95% EtOH); 1H NMR (CDCl3, 500 MHz) δ
8.12−8.10 (m, 4H), 7.78−7.74 (m, 6H), 7.72 (s, 2H), 7.47−7.41 (m, 8H), 4.86−4.80 (m,
2H), 4.48 (t, J = 9.0 Hz, 2H), 4.26 (t, J = 8.5 Hz, 2H), 3.51 (dd, J = 14.0, 5.0 Hz, 2H),
3.03 (dd, J = 14.0, 9.0 Hz, 2H); 13C NMR (CDCl3, 125 MHz) δ 161.7 (2C), 154.2 (2C),
135.5 (2C), 133.5 (2C), 132.3 (2C), 128.7 (2C), 128.2 (2C), 127.8 (2C), 127.7 (2C),
127.6 (2C), 127.5 (2C), 126.1 (2C), 125.5 (2C), 124.8 (2C), 123.7 (2C), 123.1 (2C),
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113.3 (2C), 71.9 (2C), 67.8 (2C), 41.8 (2C); IR (film) νmax 3052, 2925, 2853, 1652, 1507,
1427, 1185, 1124, 984 cm–1; HRMS (ESI) m/z 587.23438 (MH+, C40H30N2O3H requires
587.23292).
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